{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:19:51Z","timestamp":1783491591457,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Melanoma, originating from the malignant change in skin melanocytes, is highly metastatic, yet effective treatments to prevent its spread are still lacking. Lysine-specific histone demethylase 1 (LSD1) functions as an epigenetic modifier; however, its role in melanoma remains incompletely elucidated. In this study, we determined that LSD1 expression is upregulated in metastatic melanoma relative to primary melanoma, which is indicative of a poor prognosis. Subsequent experiments revealed that targeting LSD1 effectively suppresses melanoma metastasis in both in vitro and in vivo models. Mechanistically, the pharmacological or genetic inhibition of LSD1 induces the phosphorylation and subsequent degradation of Yes-associated protein (YAP), a critical component of the Hippo signaling pathway that is strongly linked to tumor metastasis. Furthermore, ChIP-qPCR analysis indicates that the LSD1 inhibition enhances H3K4me2 modification at the promoter regions of\n                    <jats:italic>NF2<\/jats:italic>\n                    and\n                    <jats:italic>LATS1\/2<\/jats:italic>\n                    , thereby promoting their transcriptional activation. This results in increased expression of NF2 (encoded by\n                    <jats:italic>NF2<\/jats:italic>\n                    ) and LATS1\/2, ultimately activating the Hippo pathway. These findings not only enhance our understanding of the molecular mechanisms driving melanoma metastasis but also establish a novel theoretical basis for the development of LSD1 inhibitors and targeted therapeutic strategies for melanoma.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08872-1","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:36:10Z","timestamp":1778895370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting lysine-specific demethylase 1 inhibits melanoma metastasis via the NF2-Hippo-YAP pathway"],"prefix":"10.1038","volume":"17","author":[{"given":"Han","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4558-0518","authenticated-orcid":false,"given":"Yichao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2679-127X","authenticated-orcid":false,"given":"Pengxing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2647-7734","authenticated-orcid":false,"given":"Linlin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"8872_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/bjd.20427","volume":"185","author":"I Yeh","year":"2021","unstructured":"Yeh I, Bastian BC. Melanoma pathology: new approaches and classification. Br J Dermatol. 2021;185:282\u201393.","journal-title":"Br J Dermatol"},{"key":"8872_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/path.2617","volume":"219","author":"S Kuphal","year":"2009","unstructured":"Kuphal S, Bosserhoff A. Recent progress in understanding the pathology of malignant melanoma. J Pathol. 2009;219:400\u20139.","journal-title":"J Pathol"},{"key":"8872_CR3","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3390\/cancers12082154","volume":"12","author":"Y Tang","year":"2020","unstructured":"Tang Y, Durand S, Dalle S, Caramel J. EMT-inducing transcription factors, drivers of melanoma phenotype switching, and resistance to treatment. Cancers. 2020;12:2154.","journal-title":"Cancers"},{"key":"8872_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fonc.2015.00031","volume":"5","author":"FZ Li","year":"2015","unstructured":"Li FZ, Dhillon AS, Anderson RL, McArthur G, Ferrao PT. Phenotype switching in melanoma: implications for progression and therapy. Front Oncol. 2015;5:31.","journal-title":"Front Oncol"},{"key":"8872_CR5","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","volume":"119","author":"Y Shi","year":"2004","unstructured":"Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004;119:941\u201353.","journal-title":"Cell"},{"key":"8872_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.apsb.2018.10.006","volume":"9","author":"L Zhu","year":"2019","unstructured":"Zhu L, Wang J, Kong W, Huang J, Dong B, Huang Y, et al. LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma via upregulating P21 signaling. Acta Pharm Sin B. 2019;9:324\u201334.","journal-title":"Acta Pharm Sin B"},{"key":"8872_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.bbagrm.2017.07.001","volume":"1860","author":"S Ambrosio","year":"2017","unstructured":"Ambrosio S, Sacc\u00e0 CD, Majello B. Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1\/KDM1A. Biochim Biophys Gene Regul Mech. 2017;1860:905\u201310.","journal-title":"Biochim Biophys Gene Regul Mech"},{"key":"8872_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13578-017-0142-x","volume":"7","author":"B Peng","year":"2017","unstructured":"Peng B, Shi R, Jiang W, Ding YH, Dong MQ, Zhu WG, et al. Phosphorylation of LSD1 by PLK1 promotes its chromatin release during mitosis. Cell Biosci. 2017;7:15.","journal-title":"Cell Biosci"},{"key":"8872_CR9","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.2337\/db21-1131","volume":"71","author":"B Ramms","year":"2022","unstructured":"Ramms B, Pollow DP, Zhu H, Nora C, Harrington AR, Omar I, et al. Systemic LSD1 inhibition prevents aberrant remodeling of metabolism in obesity. Diabetes. 2022;71:2513\u201329.","journal-title":"Diabetes"},{"key":"8872_CR10","doi-asserted-by":"crossref","unstructured":"Martinez-Gamero C, Malla S, Aguilo F. LSD1: expanding functions in stem cells and differentiation. Cells. 2021;10:3252.","DOI":"10.3390\/cells10113252"},{"key":"8872_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.theriogenology.2024.05.010","volume":"224","author":"J Qi","year":"2024","unstructured":"Qi J, Zhang S, Qu H, Wang Y, Dong Y, Wei H, et al. Lysine-specific demethylase 1 (LSD1) participate in porcine early embryonic development by regulating cell autophagy and apoptosis through the mTOR signaling pathway. Theriogenology. 2024;224:119\u201333.","journal-title":"Theriogenology"},{"key":"8872_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217093","volume":"598","author":"W Cai","year":"2024","unstructured":"Cai W, Xiao C, Fan T, Deng Z, Wang D, Liu Y, et al. Targeting LSD1 in cancer: Molecular elucidation and recent advances. Cancer Lett. 2024;598:217093.","journal-title":"Cancer Lett"},{"key":"8872_CR13","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948597","volume":"21","author":"J Liu","year":"2020","unstructured":"Liu J, Feng J, Li L, Lin L, Ji J, Lin C, et al. Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer. EMBO Rep. 2020;21:e48597.","journal-title":"EMBO Rep"},{"key":"8872_CR14","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.167440","volume":"8","author":"A Kumaraswamy","year":"2023","unstructured":"Kumaraswamy A, Duan Z, Flores D, Zhang C, Sehrawat A, Hu YM, et al. LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function. JCI Insight. 2023;8:e167440.","journal-title":"JCI Insight"},{"key":"8872_CR15","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1158\/1078-0432.CCR-22-1128","volume":"28","author":"JB Hiatt","year":"2022","unstructured":"Hiatt JB, Sandborg H, Garrison SM, Arnold HU, Liao SY, Norton JP, et al. Inhibition of LSD1 with bomedemstat sensitizes small cell lung cancer to immune checkpoint blockade and T-cell killing. Clin Cancer Res. 2022;28:4551\u201364.","journal-title":"Clin Cancer Res"},{"key":"8872_CR16","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.gendis.2022.11.002","volume":"10","author":"P He","year":"2023","unstructured":"He P, Du L, Hao P, Yang H, Ren Y, Kang H, et al. Inhibition of lysine-specific demethylase 1 (LSD1) prevented tumor growth and metastasis by downregulating PD-L1 expression in lung adenocarcinoma. Genes Dis. 2023;10:1779\u201382.","journal-title":"Genes Dis"},{"key":"8872_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120275","volume":"291","author":"N Li","year":"2022","unstructured":"Li N, Yang L, Zuo H. Arborinine suppresses ovarian cancer development through inhibition of LSD1. Life Sci. 2022;291:120275.","journal-title":"Life Sci"},{"key":"8872_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/bjc.2013.364","volume":"109","author":"J Ding","year":"2013","unstructured":"Ding J, Zhang ZM, Xia Y, Liao GQ, Pan Y, Liu S, et al. LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer. Br J Cancer. 2013;109:994\u20131003.","journal-title":"Br J Cancer"},{"key":"8872_CR19","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.3892\/or.2016.5099","volume":"36","author":"L Yi","year":"2016","unstructured":"Yi L, Cui Y, Xu Q, Jiang Y. Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway. Oncol Rep. 2016;36:2935\u201345.","journal-title":"Oncol Rep"},{"key":"8872_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41419-020-2729-0","volume":"11","author":"Y Lian","year":"2020","unstructured":"Lian Y, Yan C, Lian Y, Yang R, Chen Q, Ma D, et al. Long intergenic non-protein-coding RNA 01446 facilitates the proliferation and metastasis of gastric cancer cells through interacting with the histone lysine-specific demethylase LSD1. Cell Death Dis. 2020;11:522.","journal-title":"Cell Death Dis"},{"key":"8872_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41556-022-00848-5","volume":"24","author":"H Li","year":"2022","unstructured":"Li H, Wu BK, Kanchwala M, Cai J, Wang L, Xing C, et al. YAP\/TAZ drives cell proliferation and tumour growth via a polyamine-eIF5A hypusination-LSD1 axis. Nat Cell Biol. 2022;24:373\u201383.","journal-title":"Nat Cell Biol"},{"key":"8872_CR22","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato F, Forcato M, Battilana G, Azzolin L, Quaranta E, Bodega B, et al. Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol. 2015;17:1218\u201327.","journal-title":"Nat Cell Biol"},{"key":"8872_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13045-017-0421-3","volume":"10","author":"YJ Huang","year":"2017","unstructured":"Huang YJ, Yang CK, Wei PL, Huynh TT, Whang-Peng J, Meng TC, et al. Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways. J Hematol Oncol. 2017;10:60.","journal-title":"J Hematol Oncol"},{"key":"8872_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ccell.2018.02.002","volume":"33","author":"T Maes","year":"2018","unstructured":"Maes T, Mascar\u00f3 C, Tirapu I, Estiarte A, Ciceri F, Lunardi S, et al. ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of acute leukemia. Cancer Cell. 2018;33:495\u2013511.e12.","journal-title":"Cancer Cell"},{"key":"8872_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10238-021-00738-4","volume":"22","author":"T Takeda","year":"2022","unstructured":"Takeda T, Tsubaki M, Genno S, Matsuda T, Yamamoto Y, Kimura A, et al. Inhibition of yes-associated protein suppresses migration, invasion, and metastasis in non-small cell lung cancer in vitro and in vivo. Clin Exp Med. 2022;22:221\u20138.","journal-title":"Clin Exp Med"},{"key":"8872_CR26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41419-023-06238-5","volume":"14","author":"L Du","year":"2023","unstructured":"Du L, Yang H, Ren Y, Ding Y, Xu Y, Zi X, et al. Inhibition of LSD1 induces ferroptosis through the ATF4-xCT pathway and shows enhanced anti-tumor effects with ferroptosis inducers in NSCLC. Cell Death Dis. 2023;14:716.","journal-title":"Cell Death Dis"},{"key":"8872_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/CS20201474","volume":"136","author":"R Cunningham","year":"2022","unstructured":"Cunningham R, Hansen CG. The Hippo pathway in cancer: YAP\/TAZ and TEAD as therapeutic targets in cancer. Clin Sci. 2022;136:197\u2013222.","journal-title":"Clin Sci"},{"key":"8872_CR28","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.molcel.2022.03.027","volume":"82","author":"S Qi","year":"2022","unstructured":"Qi S, Zhu Y, Liu X, Li P, Wang Y, Zeng Y, et al. WWC proteins mediate LATS1\/2 activation by Hippo kinases and imply a tumor suppression strategy. Mol Cell. 2022;82:1850\u201364.e7.","journal-title":"Mol Cell"},{"key":"8872_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107324","volume":"91","author":"W Jingjing","year":"2021","unstructured":"Jingjing W, Zhikai W, Xingyi Z, Peixuan L, Yiwu F, Xia W, et al. Lysine-specific demethylase 1 (LSD1) serves as an potential epigenetic determinant to regulate inflammatory responses in mastitis. Int Immunopharmacol. 2021;91:107324.","journal-title":"Int Immunopharmacol"},{"key":"8872_CR30","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1038\/s41388-022-02471-y","volume":"41","author":"A Maiques-Diaz","year":"2022","unstructured":"Maiques-Diaz A, Nicosia L, Basma NJ, Romero-Camarero I, Camera F, Spencer GJ, et al. HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block. Oncogene. 2022;41:4841\u201354.","journal-title":"Oncogene"},{"key":"8872_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s41588-020-0681-7","volume":"52","author":"S Gao","year":"2020","unstructured":"Gao S, Chen S, Han D, Wang Z, Li M, Han W, et al. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer. Nat Genet. 2020;52:1011\u20137.","journal-title":"Nat Genet"},{"key":"8872_CR32","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.jmb.2016.12.016","volume":"429","author":"Y Jang","year":"2017","unstructured":"Jang Y, Wang C, Zhuang L, Liu C, Ge K. H3K4 methyltransferase activity is required for MLL4 protein stability. J Mol Biol. 2017;429:2046\u201354.","journal-title":"J Mol Biol"},{"key":"8872_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105335","volume":"164","author":"S Zhang","year":"2021","unstructured":"Zhang S, Liu M, Yao Y, Yu B, Liu H. Targeting LSD1 for acute myeloid leukemia (AML) treatment. Pharm Res. 2021;164:105335.","journal-title":"Pharm Res"},{"key":"8872_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572:402\u20136.","journal-title":"Nature"},{"key":"8872_CR35","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/1878-0261.12896","volume":"15","author":"M Mota","year":"2021","unstructured":"Mota M, Metge BJ, Hinshaw DC, Alsheikh HA, Chen D, Samant RS, et al. Merlin deficiency alters the redox management program in breast cancer. Mol Oncol. 2021;15:942\u201356.","journal-title":"Mol Oncol"},{"key":"8872_CR36","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nsmb.2084","volume":"18","author":"OG McDonald","year":"2011","unstructured":"McDonald OG, Wu H, Timp W, Doi A, Feinberg AP. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol. 2011;18:867\u201374.","journal-title":"Nat Struct Mol Biol"},{"key":"8872_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13277-012-0525-x","volume":"34","author":"ZK Zhao","year":"2013","unstructured":"Zhao ZK, Dong P, Gu J, Chen L, Zhuang M, Lu WJ, et al. Overexpression of LSD1 in hepatocellular carcinoma: a latent target for the diagnosis and therapy of hepatoma. Tumour Biol. 2013;34:173\u201380.","journal-title":"Tumour Biol"},{"key":"8872_CR38","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.neo.2014.10.006","volume":"16","author":"G Ferrari-Amorotti","year":"2014","unstructured":"Ferrari-Amorotti G, Chiodoni C, Shen F, Cattelani S, Soliera AR, Manzotti G, et al. Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity. Neoplasia. 2014;16:1047\u201358.","journal-title":"Neoplasia"},{"key":"8872_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1158\/0008-5472.CAN-12-1739","volume":"73","author":"G Ferrari-Amorotti","year":"2013","unstructured":"Ferrari-Amorotti G, Fragliasso V, Esteki R, Prudente Z, Soliera AR, Cattelani S, et al. Inhibiting interactions of lysine demethylase LSD1 with snail\/slug blocks cancer cell invasion. Cancer Res. 2013;73:235\u201345.","journal-title":"Cancer Res"},{"key":"8872_CR40","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jcb.29353","volume":"121","author":"J Li","year":"2020","unstructured":"Li J, Yang R, Yang H, Chen S, Wang L, Li M, et al. NCAM regulates the proliferation, apoptosis, autophagy, EMT, and migration of human melanoma cells via the Src\/Akt\/mTOR\/cofilin signaling pathway. J Cell Biochem. 2020;121:1192\u2013204.","journal-title":"J Cell Biochem"},{"key":"8872_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00493-7","volume":"8","author":"G Chhabra","year":"2024","unstructured":"Chhabra G, Singh CK, Ndiaye MA, Su S, Shirley CA, Ahmad N. Role of PLK1\/NUMB\/NOTCH in epithelial-mesenchymal transition in human melanoma. npj Precis Oncol. 2024;8:6.","journal-title":"npj Precis Oncol"},{"key":"8872_CR42","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41401-021-00673-w","volume":"43","author":"LL Chang","year":"2022","unstructured":"Chang LL, Li YK, Zhao CX, Zeng CM, Ge FJ, Du JM, et al. AKR1C1 connects autophagy and oxidative stress by interacting with SQSTM1 in a catalytic-independent manner. Acta Pharmacol Sin. 2022;43:703\u201311.","journal-title":"Acta Pharmacol Sin"},{"key":"8872_CR43","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1349-7006.2010.01511.x","volume":"101","author":"Y Wang","year":"2010","unstructured":"Wang Y, Dong Q, Zhang Q, Li Z, Wang E, Qiu X. Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci. 2010;101:1279\u201385.","journal-title":"Cancer Sci"},{"key":"8872_CR44","doi-asserted-by":"publisher","first-page":"E2441","DOI":"10.1073\/pnas.1212021109","volume":"109","author":"JM Lamar","year":"2012","unstructured":"Lamar JM, Stern P, Liu H, Schindler JW, Jiang ZG, Hynes RO. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc Natl Acad Sci USA. 2012;109:E2441\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8872_CR45","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/onc.2014.5","volume":"34","author":"M Bartucci","year":"2015","unstructured":"Bartucci M, Dattilo R, Moriconi C, Pagliuca A, Mottolese M, Federici G, et al. TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells. Oncogene. 2015;34:681\u201390.","journal-title":"Oncogene"},{"key":"8872_CR46","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41419-018-0515-z","volume":"9","author":"M Yu","year":"2018","unstructured":"Yu M, Chen Y, Li X, Yang R, Zhang L, Huangfu L, et al. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD. Cell Death Dis. 2018;9:464.","journal-title":"Cell Death Dis"},{"key":"8872_CR47","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther. 2022;7:376.","journal-title":"Signal Transduct Target Ther"},{"key":"8872_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.devcel.2019.06.003","volume":"50","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Pan D. The Hippo signaling pathway in development and disease. Dev Cell. 2019;50:264\u201382.","journal-title":"Dev Cell"},{"key":"8872_CR49","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.canlet.2020.11.033","volume":"499","author":"G Kim","year":"2021","unstructured":"Kim G, Bhattarai PY, Lim SC, Kim JY, Choi HS. PIN1 facilitates ubiquitin-mediated degradation of serine\/threonine kinase 3 and promotes melanoma development via TAZ activation. Cancer Lett. 2021;499:164\u201374.","journal-title":"Cancer Lett"},{"key":"8872_CR50","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M, Piccolo S. YAP\/TAZ at the roots of cancer. Cancer Cell. 2016;29:783\u2013803.","journal-title":"Cancer Cell"},{"key":"8872_CR51","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1101\/gad.333435.119","volume":"34","author":"AW Hong","year":"2020","unstructured":"Hong AW, Meng Z, Plouffe SW, Lin Z, Zhang M, Guan KL. Critical roles of phosphoinositides and NF2 in Hippo pathway regulation. Genes Dev. 2020;34:511\u201325.","journal-title":"Genes Dev"},{"key":"8872_CR52","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.celrep.2017.07.032","volume":"20","author":"KT Furukawa","year":"2017","unstructured":"Furukawa KT, Yamashita K, Sakurai N, Ohno S. The epithelial circumferential actin belt regulates YAP\/TAZ through nucleocytoplasmic shuttling of Merlin. Cell Rep. 2017;20:1435\u201347.","journal-title":"Cell Rep"},{"key":"8872_CR53","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cell.2010.01.029","volume":"140","author":"W Li","year":"2010","unstructured":"Li W, You L, Cooper J, Schiavon G, Pepe-Caprio A, Zhou L, et al. Merlin\/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell. 2010;140:477\u201390.","journal-title":"Cell"},{"key":"8872_CR54","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","volume":"19","author":"D Pan","year":"2010","unstructured":"Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19:491\u2013505.","journal-title":"Dev Cell"},{"key":"8872_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ccr.2014.05.001","volume":"26","author":"W Li","year":"2014","unstructured":"Li W, Cooper J, Zhou L, Yang C, Erdjument-Bromage H, Zagzag D, et al. Merlin\/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. Cancer Cell. 2014;26:48\u201360.","journal-title":"Cancer Cell"},{"key":"8872_CR56","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.molcel.2016.10.034","volume":"64","author":"SW Plouffe","year":"2016","unstructured":"Plouffe SW, Meng Z, Lin KC, Lin B, Hong AW, Chun JV, et al. Characterization of Hippo pathway components by gene inactivation. Mol Cell. 2016;64:993\u20131008.","journal-title":"Mol Cell"},{"key":"8872_CR57","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13046-024-03225-2","volume":"43","author":"X Bai","year":"2024","unstructured":"Bai X, Liu J, Zhou S, Wu L, Feng X, Zhang P. METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer. J Exp Clin Cancer Res. 2024;43:307.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08872-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:02:02Z","timestamp":1783490522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08872-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8872"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08872-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were performed according to the institutional ethical guidelines established by the ethics committee of Zhengzhou University (China). The animal ethics number is 24-IACUC-Y007 and 25-YXY-088.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS"}}],"article-number":"626"}}